FENC (STOCKS)
Fennec Pharmaceuticals Inc. Common Stock
$5.930000
+0.120000 (+2.07%)
Prev close: $5.810000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jeffrey S Hackman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $205.71M
- Employees
- 32
- P/E (TTM)
- -17.23
- P/B (TTM)
- 5.60
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.10 | $0.04 | -0.1357 | -380.11% |
|
Sep 2025 (Q3)
|
$-0.02 | $-0.02 | +0.0018 | +8.26% |
|
Jun 2025 (Q2)
|
$-0.11 | $-0.04 | -0.0733 | -199.73% |
|
Mar 2025 (Q1)
|
$-0.04 | $-0.09 | +0.0506 | +55.85% |
Financial Statements
| Revenues | $44.64M |
| Benefits Costs and Expenses | $54.28M |
| Costs And Expenses | $54.28M |
| Nonoperating Income/Loss | -$3.35M |
| Operating Expenses | $50.92M |
| Research and Development | $250.00K |
| Other Operating Expenses | $50.67M |
| Operating Income/Loss | -$6.28M |
| Income/Loss From Continuing Operations After Tax | -$9.74M |
| Income/Loss From Continuing Operations Before Tax | -$9.64M |
| Income Tax Expense/Benefit | $106.00K |
| Net Income/Loss | -$9.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.34 |
| Diluted Earnings Per Share | -$0.34 |
| Basic Average Shares | 28,577,000 |
| Diluted Average Shares | 28,577,000 |
| Assets | $70.55M |
| Current Assets | $67.04M |
| Prepaid Expenses | $3.74M |
| Other Current Assets | $63.31M |
| Noncurrent Assets | $3.51M |
| Liabilities | $35.08M |
| Current Liabilities | $10.52M |
| Accounts Payable | $4.64M |
| Other Current Liabilities | $5.88M |
| Noncurrent Liabilities | $24.56M |
| Equity | $35.47M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $35.47M |
| Liabilities And Equity | $70.55M |
| Net Cash Flow From Operating Activities | -$12.47M |
| Net Cash Flow From Operating Activities, Continuing | -$12.47M |
| Net Cash Flow From Investing Activities | -$10.15M |
| Net Cash Flow From Investing Activities, Continuing | -$10.15M |
| Net Cash Flow From Financing Activities | $22.63M |
| Net Cash Flow From Financing Activities, Continuing | $22.63M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$9.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.74M |
| Other Comprehensive Income/Loss | $0.00 |